Key terms
About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AMGN news
Today
12:29am ET
Analyst Holds on Amgen’s Tezspire amid COPD Trial Uncertainties and Pending Competitor Comparisons
Yesterday
5:45am ET
Buy Rating on Amgen: Tezspire’s Market Potential in COPD Treatment Undervalued
Yesterday
3:25am ET
Barclays Keeps Their Sell Rating on Amgen (AMGN)
Apr 16
5:28pm ET
Amgen to present Tezspire Phase 2a COPD data at ATS 2024
Apr 15
8:01am ET
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Notable Labs (NTBL)
Apr 15
7:40am ET
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)
Apr 15
7:22am ET
Amgen price target lowered to $360 from $370 at TD Cowen
Apr 11
9:56am ET
Early notable gainers among liquid option names on April 11th
Apr 03
7:00am ET
Analysts’ Top Healthcare Picks: Amgen (AMGN), Intra-Cellular Therapies (ITCI)
Mar 25
8:01am ET
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Amgen (AMGN) and Petiq (PETQ)
Mar 08
7:30am ET
Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Regeneron (REGN)
Mar 01
5:10am ET
Amgen upgraded to Conviction Buy from Buy at Goldman Sachs
Mar 01
1:12am ET
Amgen’s Sell Rating Justified by Emerging Competition and Safety Concerns in Obesity Drug Market
Feb 29
5:50am ET
Analysts’ Top Healthcare Picks: Amgen (AMGN), Sarepta Therapeutics (SRPT)
Feb 26
10:06am ET
Jefferies biotechnology analyst to hold an analyst/industry conference call
Feb 26
9:03am ET
Amgen opens state-of-the-art biomanufacturing facility in central Ohio
Feb 26
12:01am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Exact Sciences (EXAS), Teleflex (TFX) and Amgen (AMGN)
Feb 25
11:30pm ET
Balanced Outlook for Amgen: Growth Potential Amidst Challenges and Uncertainties
Feb 23
7:26am ET
Buy Rating Affirmed: Growth and Expansion in Amgen’s Rare Disease Portfolio Post-Horizon Acquisition
Feb 23
5:56am ET
Amgen’s Strategic Growth and Market Expansion in Rare Diseases Bolster Buy Rating
Feb 23
5:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Alnylam Pharma (ALNY) and Bausch Health Companies (BHC)
Feb 23
3:15am ET
Barclays Sticks to Their Sell Rating for Amgen (AMGN)
Feb 22
3:55pm ET
Amgen to host conference call
Feb 22
4:55am ET
Amgen to host conference call
Feb 19
3:39pm ET
Amgen to host conference call
Feb 19
9:15am ET
Amgen (AMGN) Receives a Buy from Wells Fargo
Feb 12
1:25pm ET
Amgen call volume above normal and directionally bullish
Feb 08
11:20pm ET
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and UnitedHealth (UNH)
Feb 07
10:32am ET
Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls
Feb 07
10:25am ET
Amgen Hold Rating Affirmed Amid Financial Outlook and Drug Pipeline Developments
Feb 07
9:09am ET
Amgen price target raised to $329 from $303 at RBC Capital
No recent press releases are available for AMGN
AMGN Financials
Key terms
Ad Feedback
AMGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AMGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
